Literature DB >> 11238745

Rapid transferrin efflux from brain to blood across the blood-brain barrier.

Y Zhang1, W M Pardridge.   

Abstract

The brain efflux index method is used to examine the extent to which transferrin effluxes from brain to blood across the blood-brain barrier (BBB) following intracerebral injection. Whereas high-molecular-weight dextran is nearly 100% retained in brain for up to 90 min after intracerebral injection in the Par2 region of the parietal cortex of brain, there is rapid efflux of transferrin from brain to blood across the BBB. The efflux of apotransferrin is 3.5-fold faster than the efflux of holo-transferrin. The brain to blood efflux of apotransferrin is completely saturable by unlabeled transferrin, but is not inhibited by other plasma proteins. These studies provide evidence for reverse transcytosis of transferrin from brain to blood across the BBB. As circulating transferrin is known to undergo transcytosis across the BBB in the blood-to-brain direction, these studies support the model of bidirectional transcytosis of transferrin through the BBB in vivo.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11238745     DOI: 10.1046/j.1471-4159.2001.00222.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  34 in total

Review 1.  The blood-brain barrier: bottleneck in brain drug development.

Authors:  William M Pardridge
Journal:  NeuroRx       Date:  2005-01

Review 2.  Brain-to-blood transporters for endogenous substrates and xenobiotics at the blood-brain barrier: an overview of biology and methodology.

Authors:  Tetsuya Terasaki; Sumio Ohtsuki
Journal:  NeuroRx       Date:  2005-01

3.  Quantitative evaluation of monocyte transmigration into the brain following chemical opening of the blood-brain barrier in mice.

Authors:  Jianmei Wu; Shiming Yang; Haiyan Luo; Lingbing Zeng; Lingbing Ye; Yuanan Lu
Journal:  Brain Res       Date:  2006-08-14       Impact factor: 3.252

Review 4.  shRNA and siRNA delivery to the brain.

Authors:  William M Pardridge
Journal:  Adv Drug Deliv Rev       Date:  2007-03-16       Impact factor: 15.470

Review 5.  Strategies to improve drug delivery across the blood-brain barrier.

Authors:  Albertus G de Boer; Pieter J Gaillard
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

Review 6.  Drug transport across the blood-brain barrier.

Authors:  William M Pardridge
Journal:  J Cereb Blood Flow Metab       Date:  2012-08-29       Impact factor: 6.200

Review 7.  Diffusion of macromolecules in the brain: implications for drug delivery.

Authors:  Daniel J Wolak; Robert G Thorne
Journal:  Mol Pharm       Date:  2013-01-31       Impact factor: 4.939

Review 8.  Nanoparticle transport across the blood brain barrier.

Authors:  Andreas M Grabrucker; Barbara Ruozi; Daniela Belletti; Francesca Pederzoli; Flavio Forni; Maria Angela Vandelli; Giovanni Tosi
Journal:  Tissue Barriers       Date:  2016-02-25

Review 9.  The effect of aging on brain barriers and the consequences for Alzheimer's disease development.

Authors:  Nina Gorlé; Caroline Van Cauwenberghe; Claude Libert; Roosmarijn E Vandenbroucke
Journal:  Mamm Genome       Date:  2016-05-03       Impact factor: 2.957

10.  Isolation of drug delivery from drug effect: problems of optimizing drug delivery parameters.

Authors:  Mir J Ali; Yot Navalitloha; Michael W Vavra; Eric W-Y Kang; Andrea C Itskovich; Peter Molnar; Robert M Levy; Dennis R Groothuis
Journal:  Neuro Oncol       Date:  2006-03-08       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.